Skip to content
Screener

Price / book at other companies

Eli Lilly logo
Eli LillyLLY
31.6×-6.7×
Aardvark Therapeutics, Inc. logo
Aardvark Therapeutics, Inc.AARD
0.9×
Viking Therapeutics logo
Viking TherapeuticsVKTX
7.5×+4.3×
Mirum Pharmaceuticals, Inc. logo
Mirum Pharmaceuticals, Inc.MIRM
23×+13.5×
TG Therapeutics logo
TG TherapeuticsTGTX
13.9×-7.5×
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
3.9×-0.5×

Other financials

Income statement

See full
Revenue$60.1M+83.8%
Gross profit$53.0M+82.3%
Operating income-$52.4M-11.4%
Net income-$55.6M-12.4%
EPS (diluted)-$0.83-2.5%

Balance sheet

See full
Cash & equivalents$62.1M-41.4%
Total debt$112.3M-1.1%
Total equity$122.9M+549%
Total assets$442.3M+14.4%

Cash flow

See full
Operating cash flow-$44.2M-9.5%
CapEx$238.3K
Free cash flow-$29.2M-2.4%

Valuation

See full
Market cap$7.62B+27.5%
Enterprise value$7.67B+28.8%
P/S35.1×-3.2×

Profitability

See full
Gross margin89.4%-0.2pp
Operating margin-90.9%-19.8pp
Net margin-93.3%-18.2pp
FCF margin-61.5%-14.1pp

Returns & leverage

See full
Return on equity-285.8%-68.9pp
Debt / equity0.9×-5.1×
Current ratio4.2×+0.9×

Where this comes from

Calculated from Rhythm Pharmaceuticals, Inc.’s reported figures.

Based on the most recent quarter.

The source filing: Rhythm Pharmaceuticals, Inc.’s 10-Q, filed May 5, 2026. Open the filing →

Filed
May 5, 2026, 4:15 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001628280-26-030549

FAQ

What is Rhythm Pharmaceuticals, Inc.'s price / book?
Rhythm Pharmaceuticals, Inc. (RYTM) reported price / book of 48.3× in Q1 2026.
How has Rhythm Pharmaceuticals, Inc.'s price / book changed year-over-year?
Rhythm Pharmaceuticals, Inc.'s price / book decreased by 72.7% year-over-year, from 176.8× to 48.3×.
What is the long-term trend for Rhythm Pharmaceuticals, Inc.'s price / book?
Over 5 years (2020 to 2025), Rhythm Pharmaceuticals, Inc.'s price / book has grown at a 41.8% compound annual growth rate (CAGR), from 9× to 51.4×.
What does price / book mean?
Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.

Ask your AI about Rhythm Pharmaceuticals, Inc.'s price / book.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude